Introduction. Lamivudine was widely used to treat chronic hepatitis B due to its’ low price and availability in the past. Due to fast evolving of resistance, lamivudine is not recommended as first treatment choice anymore; however it was noticed that patients, who previously developed resistance to lamivudine, also develop resistance to entecavir.
EN